Diabetes in the News
Chromium Picolinate Shows Greater Clinical Benefits
Nutrition 21, Inc. (Nasdaq: NXXI) reported today that a peer-reviewed analysis on chromium picolinate was published in the current edition of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. The review, which analyzed [...]
This post does not allow comments



